Chronic Kidney Disease in Type 2 Diabetes
Bayer funds educational programs to improve early diagnosis, screening, and management of chronic kidney disease in type 2 diabetes, focusing on guideline-based practices and cardio-renal risk reduction.
Funder: Bayer
Due Dates: Rolling (monthly review; submit anytime)
Funding Amounts: Not specified; detailed budget required with application.
Summary: Supports educational initiatives to improve early diagnosis and management of chronic kidney disease in type 2 diabetes, with emphasis on screening, risk reduction, and cardio-renal event awareness.
Key Information: Allow at least 45 days from submission for a response; proposals must meet ACCME or similar standards.
Description
This grant opportunity from Bayer supports medical education programs focused on chronic kidney disease (CKD) in patients with type 2 diabetes. The goal is to improve understanding and implementation of guideline-recommended screening practices (such as urine albumin-creatinine ratio and estimated glomerular filtration rate), raise awareness of cardio-renal events in diabetic kidney disease, and promote strategies to minimize cardiovascular risks and slow CKD progression. Supported educational formats include enduring materials, downloadable slides, social media outreach, podcasts, and live virtual events. The initiative is aimed at enhancing the knowledge and practice of healthcare professionals managing CKD in diabetes.
